MOSQUIRIX, WORLD*S FIRST MALARIA VACCINE, GETS APPROVAL FROM REGULATORS
##Pharmaceutical giant Glaxo Smith Kline said its vaccine called RTS, S or Mosquirix, which has been developed in collaboration with the PATH Malaria Vaccine Initiative, will be the first licensed human vaccine against malaria// (UsA) ©
## The drugs called RTS, or Mosquirix and developed by drugmaker Glaxo Smith Kline in partnership with the PATH Malaria Vaccine Initiative could prove useful in preventing millions of cases of malaria in countries that will use it// ©
## It has been said that the recommendations for a drug license by the European Medicines Agency are normally endorsed by the European Commission within a couple of months// ©
## Mosquirix, which is also partly funded by the Bill - Melinda Gates Foundation, will now be assessed by the World Health Organization// The WHO will lay out guidance plan on where and when the drug will be used before the end of this year//(UsA) ©
## As per reports, malaria infects around 200 million people every year and has killed an estimated 584,000 in 2013, with majority of causalities in sub Saharan Africa, (UsA)// ©
## Andrew Witty, GSK*s chief executive, said in a statement that EMA*s positive recommendation was very important step in making the vaccine the world*s first malaria vaccine available// ©